Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist.
Authors
Boccellato, ChiaraKolbe, Emily
Peters, Nathalie
Juric, Viktorija
Fullstone, Gavin
Verreault, Maïté
Idbaih, Ahmed
Lamfers, Martine L M
Murphy, Brona M
Rehm, Markus
Issue Date
2021-06-24Keywords
GLIOBLASTOMADRUG THERAPY
BRAIN
Metadata
Show full item recordJournal
Cell death & diseaseDOI
10.1038/s41419-021-03927-xPubMed ID
34168123Item Type
ArticleOther
Language
enEISSN
2041-4889ae974a485f413a2113503eed53cd6c53
10.1038/s41419-021-03927-x
Scopus Count
Collections
Related articles
- Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier.
- Authors: Di K, Lloyd GK, Abraham V, MacLaren A, Burrows FJ, Desjardins A, Trikha M, Bota DA
- Issue date: 2016 Jun
- The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
- Authors: Rosato RR, Almenara JA, Coe S, Grant S
- Issue date: 2007 Oct 1
- KAAD-cyclopamine augmented TRAIL-mediated apoptosis in malignant glioma cells by modulating the intrinsic and extrinsic apoptotic pathway.
- Authors: Siegelin MD, Siegelin Y, Habel A, Rami A, Gaiser T
- Issue date: 2009 May
- Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism.
- Authors: Lincoln FA, Imig D, Boccellato C, Juric V, Noonan J, Kontermann RE, Allgöwer F, Murphy BM, Rehm M
- Issue date: 2018 Nov 1
- Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis.
- Authors: Murphy ÁC, Weyhenmeyer B, Noonan J, Kilbride SM, Schimansky S, Loh KP, Kögel D, Letai AG, Prehn JH, Murphy BM
- Issue date: 2014 Apr